We reiterate BUY and raise our target price (TP) by 14% thanks to (1) DGC’s higher net cash balance as of Q1 2022 and (2) our 20%/12% upward revisions to 2022F/2023F core EBITDA as DGC’s selling prices are tracking ahead of our expectations, which are par